Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

YES Oklahoma: Building Pathways into Cancer Research and Public Health for Indigenous High School Students.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy.

Extracellular vesicles and circulating nucleic acids·2026
Same author

BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung Cancer.

Cancers·2026
Same author

Antibody Generation Using Cancer-Derived Small Extracellular Vesicles (sEVs): A Platform for Targeted Cancer Therapy and Potential Personalized Applications.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Challenges and opportunities for treatment of medulloblastoma.

Advances in cancer research·2025
Same author

Interleukin-24: A Multidimensional Therapeutic for Treatment of Human Diseases.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2025

Related Experiment Video

Updated: Jan 31, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

2.1K

Cancer targeting using tumor suppressor genes.

Sunil Chada1, Kerstin B Menander, Dora Bocangel

  • 1Department of Clinical Research and Development, Introgen Research Institute, Introgen Therapeutics Inc., Houston, Texas 77030, USA. s.chada@introgen.com

Frontiers in Bioscience : a Journal and Virtual Library
|November 6, 2007
PubMed
Summary

Targeted cancer therapies aim to selectively kill tumor cells while sparing healthy tissues. This review explores using tumor suppressor genes, like p53, to develop novel, tumor-specific cancer drugs.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

13.3K

Related Experiment Videos

Last Updated: Jan 31, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

2.1K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

13.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Conventional cancer treatments (chemotherapy, radiotherapy) cause significant side effects due to lack of tumor selectivity.
  • Advancements in understanding cancer biology are driving the development of targeted therapies.
  • There is a critical need for cancer treatments with improved tumor selectivity and reduced iatrogenic damage.

Purpose of the Study:

  • To review the potential of tumor suppressor genes as a basis for developing novel cancer-selective drugs.
  • To highlight the tumor suppressor p53 as a key example for targeted drug development.
  • To discuss strategies for leveraging tumor suppressor gene functions in cancer therapy.

Main Methods:

  • Literature review of current research on tumor suppressor genes and targeted cancer therapy.
  • Analysis of the role of p53 in tumor suppression and its potential as a therapeutic target.
  • Discussion of drug development strategies focusing on tumor selectivity.

Main Results:

  • Tumor suppressor genes offer a promising avenue for developing drugs that specifically target cancer cells.
  • The p53 tumor suppressor provides a strong archetype for understanding and exploiting tumor suppressor gene function in drug design.
  • Targeted approaches can potentially minimize collateral damage to healthy tissues.

Conclusions:

  • Harnessing tumor suppressor genes, exemplified by p53, represents a significant opportunity for advancing cancer treatment.
  • Future cancer therapies will likely focus on molecular mechanisms for enhanced tumor selectivity.
  • Developing drugs based on tumor suppressor gene function could lead to more effective and less toxic cancer treatments.